Consistent with the results from TCGA, our data also showed that higher tumor CD39 in HCC patients was associated with poorer prognosis in terms of shorter OS and earlier recurrence (Additional file 1: Fig. S6F and G). Here, ENTPD1 is linked to hepatocellular carcinoma.